Researchers say they hope to launch a clinical trial to test bumetanide, a diuretic approved in 2002, but how it might improve neural functioning is unclear.
In this virtual symposium, brought to you by 10x Genomics, an expert panel will examine how single cell multiomic techniques shape the understanding of immune cell heterogeneity and immune function.
The In-Cell Western™ Assay enables scientists to identify proteins in cells grown in microplates, combining the specificity of Western blotting with the replicability and throughput of ELISAs. Download this guide from LI-COR to learn more.
Frankenstein, Mary Shelley’s 1818 masterpiece, has stood the test of time. The book still resonates with readers today, and it continues to spawn numerous cultural tendrils, from movies and television shows to Halloween costumes and songs. The character of Victor Frankenstein, the prototypical “mad scientist,” throws caution and ethics to the wind in order to complete his research, and inadvertently creates the “monster” that now resides in the Mount Rushmore of horror. We will discuss the book, raise questions, and share observations on October 29 in a webinar attended by special guest Roslynn Haynes, author and associate professor of English at the University of New South Wales.
Thanks for reading! I'm Christie, and I curate and edit this newsletter. My inbox is always open, so if you have thoughts or ideas about this newsletter or tips for our news team, I'd love to hear from you.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com
%20october%2018%20symp.jpg?upscale=true&width=320&height=320&upscale=true&name=800x800%20(1)%20october%2018%20symp.jpg "How Cellular Heterogeneity Drives Immune Responses")
